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2Yin Chen Hao (Artemisia capillaris Thunb, 茵陳蒿, Yīn 
Chén Hāo), also known as Yin Chen, Capillary or Oriental 
Wormwood belonging to Asteracea family, is a traditional 
Chinese medicine. Yin Chen Hao was first documented in The 
Divine Husbandman’s Herbal Foundation Canon (神農本草經 
shén nóng běn cǎo jīng) for treating hepatic diseases. According 
to Chinese Pharmacopoeia (中華藥典 Zhōng Huá Yào Diǎn), 
Yin Chen can be referred to two kinds of herbs: one is Artemisia 
scoparia Waldst et Kit and the other is Artemisia Capillaris. Yin 
Chen must be harvested for its aerial part in spring to exhibit 
pharmacologic effects. An old saying, “Yin Chen can be used 
as Yin Chen for treating diseases in February, but can only be 
used as lumber for burning in May (二月茵陳三月蒿,五月茵
陳當柴燒)”, indicates huge difference in bioactive component 
contents of Yin Chen Hao in different seasons.
Hepatic disorders
Yin Chen Hao traditionally was used to treat liver and 
choleretic disorders. Recently, Yin Chen was found to exhibit 
hepatoprotective effect by ameliorating murine concanavalin A 
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(con A)-induced hepatitis via suppression of interferon (IFN)-g 
and interleukin (IL)-12 production.[1] In the following study, 
orally administrated Artemisiae Capillaris (AC) group (500, 
1000, or 2000 mg/10 ml/kg) can decrease serum transaminases 
activities and IFN-g concentration in vivo.[1] Capillarisin, a 
flavonoid constituent of Yin Chen, is contained in the fraction 
and has potent hepatoprotective activity in vivo. In vitro IFN-g 
production was significantly suppressed by capillarisin in con 
A-stimulated splenocyte culture and nitrite release from IFN-
g-stimulated macrophages was also decreased. Another study 
also showed that Yin Chen may prevent the EtOH-induced 
cytotoxicity on human hepatoma cell line and Hep G2 cell.[2] 
Aqueous extract of AC (0.5–5 μg/mL) inhibited the secretion 
of EtOH-induced interluekin-1α (IL-1α) and tumor necrosis 
factor-α (TNF-α). AC also inhibited the EtOH-, IL-1α, and 
TNF-α-induced cytotoxicities. Furthermore, AC was found 
to inhibit the EtOH-induced apoptosis of Hep G2 cells. Water 
extract of Artemisia capillaries (ACWE) was capable of ame-
liorating the 2,2¢-azobis(2-amidinopropane) dihydrochloride 
(AAPH)-induced hepatic injury by catechin antioxidant activ-
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ity in vivo.[3] ACWE (7.5 g/kg) was orally administered for 7 
days before AAPH treatment (60 mg/kg). The treated group 
significantly reduced hepatic damage by lowering the levels of 
enzyme markers, such as glutamic oxaloacetic transaminase and 
glutamic pyruvic transaminase and attenuating the accumula-
tion of thiobarbituric acid-reactive substances (TBARS) in both 
plasma and liver tissues compared with AAPH alone. High-
performance liquid chromatography results showed that cat-
echin composition in the ACWE are 28% (–)-epigallocatechin 
gallate, 49% (–)-epigallocatechin, and 23% other catechins. 
Another study also indicated ethyl acetate fraction of AC (100 
mg/ml) protected Chinese hamster lung fibroblasts (V79) cells 
against oxidative stress and increased cell viability by enhanc-
ing the antioxidative activity.[4] The ethyl acetate fraction of 
AC scavenged intracellular reactive oxygen species (ROS) and 
increased the activities of cellular antioxidant enzymes like 
superoxide dismutase (SOD), glutathione peroxidase (GPx), 
catalase (CAT), and glutathione (GSH) content, resulting in 
preventing lipid peroxidation by inhibiting TBARS formation. 
Interestingly, the antihepatofibrotic effects of water extract of 
AC and Artemisia iwayomogi (AI), both long-term been used 
for hepatotherapeutic medicine in Korea, were comparatively 
analyzed using a carbon tetrachloride (CCl4)-induced liver 
fibrosis rat model.[5] The results showed that AI exerts greater 
hepatoprotective and antifibrotic effects as compared with 
AC via enhancing antioxidant capacity and down-regulating 
fibrogentic cytokines. Besides, scientific evidence was found 
to account for Yin Chen’s effect on treating jaundice.[6,7] The 
constitutive androstane receptor (CAR, NR1I3) was identified 
as a key regulator of bilirubin clearance in the liver. Treatment 
of wild-type and humanized CAR transgenic mice with AC 
for 3 days accelerates the clearance of intravenously infused 
bilirubin, but this effect is absent in CAR knockout animals. 
Expression of bilirubin glucuronyl transferase and other com-
ponents of the bilirubin metabolism pathway was induced by 
Yin Chen treatment of WT mice or mice expressing only human 
CAR, but not CAR knockout animals.
Diabetes
Besides hepatic disorders, AC also showed effect on diabetic 
studies. ß-Cell destruction by cytokines is important event in 
insulin-dependent diabetes mellitus.[8] Nitric oxide synthase 
(iNOS) expression and nitric oxide (NO) production, stimulated 
by cytokines, lead to insulin insufficiency. ACWE (100–500 
mg/ml) completely and dose-dependently protected IL-1ß and 
IFN-γ-mediated cytotoxicity on RINm5F (RIN) rat insulinoma 
cells.[9] Reduction of IL-1ß and IFN-γ-induced NO production 
correlated well with reduced levels of the iNOS mRNA and 
protein, which molecular mechanism involved the inhibition 
of nuclear factor kappa B (NF-κB) activation.[9] Another study 
also reported that AC demonstrated the highest advanced gly-
cation endproducts (AGE) inhibitory activity among several 
indigenous Artemisia species.[10] Glycation can lead to the onset 
of diabetic complications due to chronic hyperglycemia. An 
acylated flavonoid glycoside, along with 11 known flavonoids, 
6 coumarins, and 2 phenolic derivatives were obtained from Yin 
Chen and evaluated their AGE inhibitory activity to establish 
structure-activity relationship (SAR). Presence of hydroxyl 
group at C-7 and a glucosyl group instead of a methoxyl group 
at C-6 may play a crucial role in AGE inhibition (coumarin 
structure, Figure 1). 
Lipid metabolism
Lipid metabolism disorders are observed in metabolic syn-
dromes. A study reported the increased lipid metabolism effect 
of the AC ethyl acetate (ACEA) fraction (0.1 g/kg bw) on high 
fat diet-induced obesity.[11] In vitro the ACEA fraction treatment 
decreased the leptin level, fat accumulation, and peroxisome 
proliferator-activated receptor-gamma (PPAR-g) expression in 
cultured 3T3-L1 adipocytes. Lipid-lowering effect was found 
in high-fat and ACEA-treated group via increased mitochon-
drial β-oxidation by increasing the activity of the rate-limiting 
enzyme, carnitine palmitoyl transferase I. Also, the activity of 
fatty acid synthase and glycerol-3-phosphate dehydrogenase, 
related to adipogenic differentiation, were markedly suppressed 
in the high-fat and ACEA-treated group, as compared with 
the high-fat group. Moreover, lowered hepatic lipid droplet 
accumulation and adipose tissue weight and size were seen in 
the ACEA-treated group. 
Skin inflammation
Yin Chen has been reported to treat skin inflammatory con-
ditions in traditional Chinese medicine. Since several allergic 
and skin inflammatory disorders are involved 5-LOX products, 
ethanol extract (70%) of the aerial parts of AC was prepared 
Figure 1. Structures of chemical constituents from Artemisia capillaries
Hung and Kuo / Journal of Traditional and Complementary Medicine 3 (2013) 2-6
4
(3–200 mg/ml) and its 5-lipoxygenase (5-LOX) inhibitory ac-
tion was studied.[12] Potent inhibitory activity (IC50 < 1.0 μg/
mL) against 5- LOX-catalyzed leukotriene production by AC 
extract was seen in ionophore-induced rat basophilic leukemia-1 
cells. Among several constituents isolated from AC, esculetin 
(ESC) and quercetin were potent inhibitors, with IC50 values of 
6.6 and 0.7 μM, respectively. Moreover, AC and ESC strongly 
inhibited edematic response in vivo against arachidonic acid-
induced ear edema in mice. 
Anticonvulsion
The anticonvulsant effects of AC and its major constitu-
ent, ESC, were studied in locomotion, myorelaxation, motor 
coordination and electroshock seizure experiments in mice.[13] 
The ethanol extract of AC (50–400 mg/kg) was orally adminis-
tered to mice 30 min prior to testing and ECT (1–5 mg/kg) was 
intraperitoneally injected. Locomotor activities and activities 
on the rota-rod did not change in treated group, suggesting 
no sedative and myorelaxation effect. However, increased 
threshold of convulsion induced by electroshock as well as 
by pentylenetetrazole was observed in AC and ECT-treated 
group. Moreover, AC and ECT treatment increased the chloride 
influx into the intracellular area in a dose-dependent manner, 
which can be inhibited by bicuculline, a GABA antagonist. 
These results indicate that GABAergic neuron was involved 
in anticonvulsive effect of AC extract or ECT.
Chemical constituents of AC were extensively studied and 
they can be divided into several categories such as essential oil, 
chromones, flavonoids, phenylalkynes, coumarins, benzoids, 
and lignans. Major and extensively investigated components of 
AC are coumarin-type compounds, especially scoparone. Sev-
eral pharmacological studies regarding scoparone were listed 
below. The structures of some constituents are listed in Figure 1.
Scoparone
Scoparone has been investigated for its bilirubin enhanc-
ing effect by up-regulating bilirubin excretion enzymes, such 
as sulfotransferase or UDP-glucuronosyltransferase 1A1.[6,14] 
Hepatic cytosolic sulfotransferase activity was increased after 
treatment with scoparone (0–10 mg/kg) in a dose and time-
dependent manner in vivo. However, the hepatic cytosolic sul-
fotransferase was not changed by the addition of scoparone in 
vitro, and was strongly inhibited by the addition of metabolites 
of scoparone, suggesting the increase of the enzyme activity 
may involve induction of enzyme proteins by the metabolites 
of scoparone. Scoparone also reported to activate CAR in 
primary hepatocytes from both WT and humanized CAR mice 
and accelerates bilirubin clearance in vivo.[7] 
Besides liver disorders, scoparone also has been studied in 
antiinflammatory activities and antidiabetic studies. Reduced 
the releases of NO and prostaglandin E2 (PGE2) upon stimu-
lation by IFN-g,/LPS or LPS were observed in unstimulated 
macrophages, but no cytotoxic effect.[15] The inhibitory effect 
was found to be related with the suppression of iNOS and 
cyclooxygenase-2 (COX-2) and attenuated the production of 
TNF-α, interleukin (IL)-113 and IL-6 in IFN-g/LPS stimulated 
RAW 264.7 cells. ACWE was found to protect cytokine-induced 
β-cell destruction.[9] Similarly, scoparone, the major coumarin 
of AC, also showed protective effect against IL-1β and IFN-
g-mediated cytotoxicity of RINm5F and preserved glucose-
stimulated insulin secretion in rat pancreatic islets.[16] Inhibition 
of NF-κB activation was identified as the molecular mechanism 
of reduced level of iNOS mRNA and protein. Another study 
also reported that NF-κB activation was inhibited by scoparone 
in U937 human monocytes activated with phorbol 12-myristate 
13-acetate (PMA).[17] Scoparone (5–100 mM) had no cytotoxic 
effect in unstimulated cells, concentration-dependently re-
versed PMA-induced toxicity and concentration-dependently 
reduced the release of IL-8 and MCP-1 protein and expression 
of IL-8 and MCP-1 mRNA levels induced by PMA. Moreover, 
scoparone inhibited the level of NF-κB–DNA complex, which 
is linked to inhibition of NF-κB subunits (NF-κB1 p50, RelA 
p65, and c-Rel p75) translocation via suppression of IκBa 
phosphorylation.
Oral administration of scoparone has shown to attenuate 
IgE-mediated allergic response in mast cells and inhibit passive 
cutaneous anaphylaxis in rats.[18] Reduced histamine release 
from rat peritoneal mast cells (RPMC) stimulated by antidini-
trophenyl IgE and deduction of the expression and secretion of 
proinflammatory cytokines, such as TNF-α and IL-6 in RPMC 
were observed in the presence of scoparone, which may be due 
to reduced calcium uptake as well as the suppressed activity of 
p38 MAPK and NF-κB. 
Similar to AC extract, the pharmacological effects of 
scoparone in a hyperlipidaemic diabetic rabbit model were 
investigated. Scoparone (5 mg/kg/day, s.c.) can reduce plasma 
lipid and lipoprotein cholesterol levels, and maintain vascular 
morphology and vascular reactivity in the hyperlipidaemic 
diabetic rabbit. These protective effects of scoparone may be 
partly related to its free radical scavenging property.[19] 
In addition, scoparone and scopoletin exhibit a potent inhibi-
tory effect on rabbit platelet aggregation induced by four types 
of agents, adenosine diphosphate (ADP), platelet activating 
factor (PAF), sodium arachidonate, and/or collagen.[20] Capil-
larisin exhibits a potent inhibitory effect on bovinelens aldose 
reductase (LAR). Finally, scoparone (50–200 μM) was reported 
to increased dopamine release into the culture medium in PC12 
cells by synapsin I phosphorylation via activation of PKA and 
CaMK II mediated by cyclic AMP levels and Ca2+ influx.[21]
Besides scoparone, other constituents also have been re-
ported to exert pharmacological effects in different fields, such 
as liver protection and antioxidation.
Esculetin
ESC was shown to reduce CCl4-induced hepatic apoptosis 
in rats.[22] ESC (100, 500 mg/kg) significantly reduced the el-
evated activities of serum alanine aminotransferase (ALT) and 
AST caused by CCl4 and significantly increased the activities of 
catalase, glutathione peroxidase (GPx), and SOD. Furthermore, 
ESC (100, 500 mg/kg) decreased the levels of the proapoptotic 
proteins (t-Bid, Bak, and Bad) and increased the levels of the 
antiapoptotic proteins (Bcl-2 and Bcl-xL). ESC inhibited the 
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release of cytochrome c from mitochondria. In addition, the 
levels of activated caspase-9 and activated caspase-3 were 
significantly decreased in rats treated with ESC than those in 
rats treated with CCl4 alone. 
Capillarisin
The effect and mechanism of capillarisin from AC on rab-
bit penile corpus cavernosum (PCC) was evaluated.[23] Capil-
larisin (10-7, 10-6, 10-5, and 10-4 M) induced precontracted 
New Zealand White rabbit (2.5–3.0 kg) penile relaxation and 
enhanced PDE5Is-induced relaxation. Capillarisin increased 
cGMP and cAMP in the perfusate. Significant inhibition of the 
relaxation was found in the application of capillarisin on PCC 
pretreated with Nv nitro-L-arginine-methyl ester (L-NAME, 
10-3 M) and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one 
(ODQ, 10-5 M), which were used to block NO synthase and 
guanylate cyclase, respectively. Capillarisin exerts the relaxing 
effect on PCC by activating the NO cGMP and adenylyl cAMP 
signaling pathways. 
In addition, capillarisin (0.01± 1.00 mg/ml) has shown in-
hibitory effects against t-butyl-hydroperoxide (t-BHP)-caused 
cytotoxicity and genotoxicity in rat primary hepatocyte cultures 
at least via two distinct pathways, stabilizing the GSH system 
and quenching free radicals of 1,1-diphenyl-2-pi-crylhydrazyl 
(DPPH).[24] 
Hyperoside (3-O-galactoside of quercetin)
Hyperoside (50, 100, and 200 mg/kg, i.p.) has found to exert 
protective effects against CCl4-induced acute liver injury in 
mice, likely due to enhancement of the antioxidative defense 
system and suppression of the inflammatory response.[25] 
The CCl4-caused elevation of serum aminotransferases, lipid 
peroxidation, and glutathione content were attenuated by hype-
roside. Prevention of portal inflammation, centrizonal necrosis, 
and Kupffer cell hyperplasia were observed in histological 
analysis. In addition, the CCl4-caused increase of protein and 
mRNA expression of TNF-α, iNOS, COX-2, and were sup-
pressed and heme oxygenase-1 (HO-1) and nuclear protein 
expression of nuclear factor erythroid 2-related factor 2 (Nrf2) 
were augmented. 
Isorhamnetin 3-O-galactoside
Isorhamnetin-3-O-galactoside (50, 100, and 200 mg/kg, i.p.) 
ameliorated CCl4-induced hepatic injury in mice by enhancing 
the antioxidative defense system and reducing the inflammatory 
signaling pathways.[26] Isorhamnetin-3-O-galactoside significantly 
decreased serum aminotransferase activities, hepatic level of malo-
ndialdehyde, and serum tumor necrosis factor-α level. The levels 
of HO-1 protein and mRNA expression were augmented by isor-
hamnetin-3-O-galactoside, while isorhamnetin-3-O-galactoside 
attenuated the increase of iNOS and COX-2 protein and mRNA 
expression levels. In addition, isorhamnetin-3-O-galactoside re-
duced the increase of NF-κB and c-Jun nuclear translocation, but 
augmented the nuclear level of Nrf2. 
Essential oil
Essential oil from AC not only has insecticide effect but 
also exerts some pharmacological effects. A study reported that 
the oil inhibited the LPS-induced expression and production 
of inflammatory mediators, such as NO and prostaglandin E2 
(PGE2), by blocking the MAPK-mediated pathways and inhibit-
ing the activation of NF-kB and AP-1.[27]
Yin Chen Hao is a long-used traditional Chinese medicine. 
In recent studies, it was proved to prevent CCl4-induced liver 
injury as well as other pharmacological effects such as anitin-
flammatory and antiobesity. This review shed some light on 
discovery and development of traditional Chinese medicine, 
Yin Chen Hao.
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